Chlamydia vaccine shows promise in early trial
A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).
Apr 12, 2024
0
60
A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).
Apr 12, 2024
0
60
Human papillomavirus (HPV) is the second most common cancer-causing virus, accounting for 690,000 cervical and other cancers each year worldwide. While the immune system usually clears HPV infections, those that persist can ...
Apr 11, 2024
0
40
Mayo Clinic researchers demonstrated a nearly 20% increase in human papillomavirus (HPV) vaccination rates among adolescents through a combination intervention approach, a new Mayo Clinic study finds. The strategy involved ...
Nov 21, 2023
0
33
A new study has been published in The Lancet Global Health showing that almost one in three men over the age of 15 are infected with at least one genital human papillomavirus (HPV) type, and one in five are infected with ...
Sep 4, 2023
0
75
Rice University bioengineers have demonstrated a low-cost, point-of-care DNA test for HPV infections that could make cervical cancer screening more accessible in low- and middle-income countries where the disease kills more ...
Jun 21, 2023
0
32
A new swab test that identifies potentially dangerous cervical cell changes up to four years before they happen has been developed by researchers from UCL and the University of Innsbruck.
Oct 20, 2022
0
55
The human papillomavirus (HPV) can cause cancer and many countries run national vaccination programs to minimize the risk. Studies involving researchers at German Cancer Research Center, Karolinska Institutet and Tampere ...
May 31, 2021
0
17
The human papillomavirus (HPV) is the main cause of several cancers, including cervical cancer, which kills almost 300,000 women around the world each year. Although vaccines offer a proven first line of defense against HPV ...
Mar 24, 2020
0
213
Viruses get a bad rap as potential cancer-causers, but at least one class of viruses that commonly live on human skin—so-called "low-risk" human papillomaviruses—appear to play an unwitting role in protecting us against ...
Oct 30, 2019
0
303
The Griffith University scientists used CRISPR-Cas9 to successfully target and treat cervical cancer tumours in vivo (via injection into live and tumour-bearing mice) using "stealth" nanoparticles.
Oct 10, 2019
0
617